FI883603A7 - Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi

Info

Publication number: FI883603A7
Authority: FI; Finland
Prior art keywords: therapeutically useful; dihydropyridine derivatives; preparing therapeutically; preparing; dihydropyridine
Prior art date: 1987-08-03

Application number

FI883603A

Other languages

English (en)

Swedish (sv)

Other versions

FI91406C (fi

FI91406B (fi

FI883603A0 (fi

Inventor

Torija Carlos Fernandez

Ramos Joaquin Alvaro Galiano

Original Assignee

Delagrange Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-03

Filing date

1988-08-01

Publication date

1989-02-04

1988-08-01 Application filed by Delagrange Lab filed Critical Delagrange Lab

1988-08-01 Publication of FI883603A0 publication Critical patent/FI883603A0/fi

1989-02-04 Publication of FI883603A7 publication Critical patent/FI883603A7/fi

1994-03-15 Application granted granted Critical

1994-03-15 Publication of FI91406B publication Critical patent/FI91406B/fi

1994-06-27 Publication of FI91406C publication Critical patent/FI91406C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

FI883603A 1987-08-03 1988-08-01 Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi FI91406C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP87401799A EP0302980B1 (fr)	1987-08-03	1987-08-03	1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments
EP87401799		1987-08-03

Publications (4)

Publication Number	Publication Date
FI883603A0 FI883603A0 (fi)	1988-08-01
FI883603A7 true FI883603A7 (fi)	1989-02-04
FI91406B FI91406B (fi)	1994-03-15
FI91406C FI91406C (fi)	1994-06-27

Family

ID=8198243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI883603A FI91406C (fi)	1987-08-03	1988-08-01	Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi

Country Status (34)

Country	Link
US (1)	US4952592A (fi)
EP (1)	EP0302980B1 (fi)
JP (1)	JPH0733383B2 (fi)
KR (1)	KR960001724B1 (fi)
CN (1)	CN1038587C (fi)
AT (1)	ATE61588T1 (fi)
BE (1)	BE1001055A4 (fi)
CA (2)	CA1306261C (fi)
CH (1)	CH675999A5 (fi)
CZ (1)	CZ282077B6 (fi)
DD (1)	DD282008A5 (fi)
DE (2)	DE3768658D1 (fi)
DK (1)	DK430288A (fi)
ES (1)	ES2007543A6 (fi)
FI (1)	FI91406C (fi)
GB (1)	GB2208861B (fi)
GR (2)	GR880100507A (fi)
HU (1)	HU204523B (fi)
IE (1)	IE60358B1 (fi)
IL (1)	IL87321A (fi)
IN (1)	IN167550B (fi)
IS (1)	IS1549B (fi)
IT (1)	IT1235013B (fi)
LU (1)	LU87297A1 (fi)
MA (1)	MA21344A1 (fi)
NO (1)	NO170934C (fi)
NZ (1)	NZ225661A (fi)
PH (1)	PH25645A (fi)
PT (1)	PT88173B (fi)
RU (1)	RU2036922C1 (fi)
SK (1)	SK541388A3 (fi)
TN (1)	TNSN88081A1 (fi)
YU (1)	YU46547B (fi)
ZA (1)	ZA885684B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5242933A (en) *	1990-07-10	1993-09-07	Adir Et Compagnie	Piperidine, tetrahydropyridine and pyrrolidine compounds
EP0854721B1 (en) *	1995-08-02	2001-10-24	Smithkline Beecham Corporation	Endothelin receptor antagonists
RU2168987C2 (ru) *	1997-04-15	2001-06-20	Санкт-Петербургская Государственная Химико-Фармацевтическая Академия	Гипотензивное средство
RU2155036C2 (ru) *	1998-11-11	2000-08-27	Азад Зияд Оглы Абышев	Средство для лечения ишемической болезни сердца
IT1304513B1 (it) *	1998-12-30	2001-03-19	Endura Spa	Processo per la sintesi di 5-(alfa-idrossialchil)benzo(1,3)diossoli.
BR0109991A (pt) *	2000-04-11	2003-05-27	Sankyo Co	Composição farmacêutica
RU2187303C2 (ru) *	2000-10-12	2002-08-20	Азад Зияд Оглы Абышев	Способ получения таблеток диуманкала - forte по 0,01 г
BR0313593A (pt)	2002-08-19	2005-07-12	Pfizer Prod Inc	Terapia de combinação para doenças hiperproliferativas
KR20070054644A (ko) *	2004-07-26	2007-05-29	액테리온 파마슈티칼 리미티드	미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
EP2111863B1 (en)	2005-10-26	2012-03-28	Asahi Kasei Pharma Corporation	Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
EP2351569B1 (en)	2005-10-26	2012-08-22	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
TW200736245A (en) *	2005-11-29	2007-10-01	Sankyo Co	Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) *	2005-11-29	2008-02-01	Sankyo Co	Acid addition salts of dihydropyridine derivatives
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
ATE547394T1 (de)	2006-12-01	2012-03-15	Bristol Myers Squibb Co	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2012037665A1 (en)	2010-09-24	2012-03-29	Oral Delivery Technology Ltd.	Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CA2909442A1 (en)	2013-04-17	2014-10-23	Pfizer Inc.	N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
HUE069590T2 (hu)	2019-01-18	2025-03-28	Astrazeneca Ab	PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3441648A (en) *	1967-02-07	1969-04-29	Smithkline Corp	Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) *	1972-04-18	1977-06-21	Bayer Aktiengesellschaft	1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) *	1982-10-27	1984-05-04	Yoshitomi Pharmaceut Ind Ltd	１，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
ES531033A0 (es) *	1984-03-27	1985-09-01	Inst Investigacion Desarrollo	Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
IE57810B1 (en) *	1984-03-27	1993-04-21	Delagrange Lab	1,4-dihydropyridine derivatives,their preparation and their use
JPH068294B2 (ja) *	1985-02-26	1994-02-02	富山化学工業株式会社	新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) *	1984-09-01	1989-06-07	FISONS plc	Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) *	1987-03-05	1989-08-21	Yamanouchi Pharmaceut Co Ltd	ピリジン誘導体及び該化合物を含有する肝疾患治療剤

1987
- 1987-08-03 DE DE8787401799T patent/DE3768658D1/de not_active Expired - Lifetime
- 1987-08-03 AT AT87401799T patent/ATE61588T1/de active
- 1987-08-03 EP EP87401799A patent/EP0302980B1/fr not_active Expired - Lifetime
1988
- 1988-07-27 LU LU87297A patent/LU87297A1/fr unknown
- 1988-07-29 YU YU147088A patent/YU46547B/sh unknown
- 1988-07-29 DE DE3825962A patent/DE3825962A1/de not_active Withdrawn
- 1988-07-29 CA CA000573422A patent/CA1306261C/fr not_active Expired - Lifetime
- 1988-08-01 MA MA21587A patent/MA21344A1/fr unknown
- 1988-08-01 JP JP63192591A patent/JPH0733383B2/ja not_active Expired - Lifetime
- 1988-08-01 FI FI883603A patent/FI91406C/fi not_active IP Right Cessation
- 1988-08-01 DD DD88318537A patent/DD282008A5/de not_active IP Right Cessation
- 1988-08-01 NO NO883406A patent/NO170934C/no unknown
- 1988-08-02 IS IS3378A patent/IS1549B/is unknown
- 1988-08-02 GB GB8818356A patent/GB2208861B/en not_active Expired - Lifetime
- 1988-08-02 SK SK5413-88A patent/SK541388A3/sk unknown
- 1988-08-02 GR GR880100507A patent/GR880100507A/el unknown
- 1988-08-02 CZ CS885413A patent/CZ282077B6/cs not_active IP Right Cessation
- 1988-08-02 ES ES8802413A patent/ES2007543A6/es not_active Expired
- 1988-08-02 TN TNTNSN88081A patent/TNSN88081A1/fr unknown
- 1988-08-02 BE BE8800893A patent/BE1001055A4/fr not_active IP Right Cessation
- 1988-08-02 US US07/227,373 patent/US4952592A/en not_active Expired - Fee Related
- 1988-08-02 NZ NZ225661A patent/NZ225661A/xx unknown
- 1988-08-02 DK DK430288A patent/DK430288A/da not_active Application Discontinuation
- 1988-08-02 KR KR1019880009867A patent/KR960001724B1/ko not_active Expired - Fee Related
- 1988-08-02 PT PT88173A patent/PT88173B/pt not_active IP Right Cessation
- 1988-08-02 CN CN88106537A patent/CN1038587C/zh not_active Expired - Fee Related
- 1988-08-02 HU HU884065A patent/HU204523B/hu not_active IP Right Cessation
- 1988-08-02 IL IL87321A patent/IL87321A/xx not_active IP Right Cessation
- 1988-08-02 IE IE236488A patent/IE60358B1/en not_active IP Right Cessation
- 1988-08-02 IT IT8848259A patent/IT1235013B/it active
- 1988-08-02 CH CH2922/88A patent/CH675999A5/fr not_active IP Right Cessation
- 1988-08-03 ZA ZA885684A patent/ZA885684B/xx unknown
- 1988-08-03 PH PH37337A patent/PH25645A/en unknown
- 1988-08-03 IN IN556/MAS/88A patent/IN167550B/en unknown
1990
- 1990-08-28 CA CA000615848A patent/CA1306262C/fr not_active Expired - Lifetime
1991
- 1991-05-22 GR GR91400660T patent/GR3001984T3/el unknown
1992
- 1992-03-31 RU SU925011204A patent/RU2036922C1/ru active

Also Published As

Publication number	Publication date
GB2208861B (en)	1991-07-17
FI91406C (fi)	1994-06-27
JPH0733383B2 (ja)	1995-04-12
TNSN88081A1 (fr)	1990-07-10
GB8818356D0 (en)	1988-09-07
ES2007543A6 (es)	1989-06-16
KR890003743A (ko)	1989-04-17
KR960001724B1 (ko)	1996-02-03
NZ225661A (en)	1990-08-28
BE1001055A4 (fr)	1989-06-20
EP0302980B1 (fr)	1991-03-13
NO883406L (no)	1989-02-06
AU606441B2 (en)	1991-02-07
SK278775B6 (sk)	1998-02-04
DE3768658D1 (de)	1991-04-18
IE60358B1 (en)	1994-06-29
IE882364L (en)	1989-02-03
FI91406B (fi)	1994-03-15
PT88173B (pt)	1995-03-01
RU2036922C1 (ru)	1995-06-09
CN1031531A (zh)	1989-03-08
IN167550B (fi)	1990-11-10
ZA885684B (en)	1989-04-26
US4952592A (en)	1990-08-28
LU87297A1 (fr)	1989-02-02
CZ282077B6 (cs)	1997-05-14
JPH01294675A (ja)	1989-11-28
IS1549B (is)	1994-06-08
FI883603A0 (fi)	1988-08-01
YU46547B (sh)	1993-11-16
IS3378A7 (is)	1989-02-04
CA1306261C (fr)	1992-08-11
CN1038587C (zh)	1998-06-03
GR880100507A (el)	1989-05-25
DE3825962A1 (de)	1989-02-16
MA21344A1 (fr)	1989-04-01
GB2208861A (en)	1989-04-19
NO883406D0 (no)	1988-08-01
HUT54142A (en)	1991-01-28
IT8848259A0 (it)	1988-08-02
NO170934B (no)	1992-09-21
CZ541388A3 (en)	1997-01-15
DK430288A (da)	1989-02-03
IL87321A (en)	1993-04-04
SK541388A3 (en)	1998-02-04
AU2033088A (en)	1989-02-09
PT88173A (pt)	1989-06-30
IL87321A0 (en)	1989-01-31
YU147088A (en)	1990-04-30
DD282008A5 (de)	1990-08-29
GR3001984T3 (en)	1992-11-23
HU204523B (en)	1992-01-28
IT1235013B (it)	1992-06-16
CH675999A5 (en)	1990-11-30
ATE61588T1 (de)	1991-03-15
PH25645A (en)	1991-08-21
NO170934C (no)	1992-12-30
CA1306262C (fr)	1992-08-11
DK430288D0 (da)	1988-08-02
EP0302980A1 (fr)	1989-02-15

Publication	Publication Date	Title
FI890282L (fi)	1989-07-21	Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI885409A7 (fi)	1989-05-24	Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi
PT88596A (pt)	1988-10-01	Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI906438L (fi)	1991-06-30	Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
FI881180L (fi)	1988-09-14	Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
FI883603A7 (fi)	1989-02-04	Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI883249A7 (fi)	1989-01-11	Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
NO176758C (no)	1995-05-24	Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
FI880816A7 (fi)	1988-09-24	Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
FI873350A7 (fi)	1988-02-05	Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
PT86660A (pt)	1988-02-01	Process for preparing adenosine 5:-carboxamide derivatives
FI890245A7 (fi)	1989-07-22	Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-disubstituoitujen piperidinyylijohdannaisten valmistamiseksi
FI884627A7 (fi)	1989-04-10	Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi
PT87717A (pt)	1988-07-01	Process for preparing 2,4-thiazolidinedione derivatives
FI880467A7 (fi)	1988-08-05	Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI883672A7 (fi)	1989-02-08	Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI881892A7 (fi)	1988-10-25	Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
FI893326A7 (fi)	1990-01-09	Menetelmä uusien terapeuttisesti käyttökelpoisten 1,3-disubstituoitujen piperidiinijohdannaisten valmistamiseksi
YU182088A (en)	1990-06-30	Process for obtaining derivatives of 4-aryl-5-carbamoyl-1,4-dihydropyridine
FI881525A7 (fi)	1988-10-02	Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi
FI885560A7 (fi)	1988-11-30	Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
FI884660L (fi)	1989-04-13	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI893003L (fi)	1989-12-21	Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
HUT45499A (en)	1988-07-28	Process for producing optically active 1,4-dihydropyridine derivatives
FI880468A7 (fi)	1988-08-05	Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi

Legal Events

Date	Code	Title	Description
1994-02-16	BB	Publication of examined application
1995-08-03	PC	Transfer of assignment of patent	Owner name: ALMIRALL-PRODESFARMA S.A.
1998-01-27	TC	Name/ company changed in patent	Owner name: ALMIRALL-PRODESFARMA S.A.
2004-08-31	MM	Patent lapsed	Owner name: ALMIRALL-PRODESFARMA S.A.